|
World Kidney Day is a joint initiative of the International Society of Nephrology (ISN) and the International Federation of Kidney Foundations (IFKF). The mission of World Kidney Day is to raise awareness of the importance of our kidneys to our overall health and to reduce the frequency and impact of kidney disease and its associated health problems worldwide. We encourage you to learn more about World Kidney Day by visiting
|
American Transplant Congress presentations
We are pleased to announce that the Adult to Adult Living Donor Liver Transplantation (A2ALL) Cohort Study and the Renal and Lung Living Donors Evaluation (RELIVE) Study will present five abstracts at the American Transplant Congress on May 18-22, 2013 in Seattle. To learn more, please click here.
|
|
Job Openings
As we continue to grow, we are looking to build a diverse and dynamic staff who can help us address pressing health-care challenges.
Project Assistant, Japan DOPPS
Research Analyst
Research Scientist
|
|
We want to hear from you!
If you have a question or a comment, please send it to Communications@ArborResearch.org
|
|
|
Greetings!
Welcome to the March issue of the Arbor Research newsletter. In celebration of World Kidney Day, March 14, 2013, we are highlighting some of our studies and findings that improve care for patients with kidney disease.
|
|
|
We are pleased to announce that Arbor Research is a pioneer member of the Kidney Health Initiative (KHI). The KHI, established in September 2012, is a partnership between the American Society of Nephrology (ASN) and the US Food and Drug Administration (FDA).
As a member of KHI, Arbor Research will be involved in the selection and execution of projects, including co-authoring white papers and collaborating to leverage clinical studies, research infrastructure, and databases. This partnership will help create a transparent infrastructure and processes that facilitate cooperation and communication among the nephrology community and the FDA.
We look forward to working with other participants in this initiative to advance scientific understanding of kidney health by creating an environment to promote research into drugs, devices, biologics, and food products in ways that can improve the lives of patients with kidney disease.
|
|
RELIVE Study of Living Kidney Donors
Do recent changes in practice lead to the acceptance of less than ideal living kidney donors? To answer this question, the Renal and Lung Living Donors Evaluation (RELIVE) Study evaluated kidney donors who donated between 1963 and 2007 at three major U.S. transplant centers. The results of this study were published in "Demographic, metabolic, and blood pressure characteristics of living kidney donors spanning five decades" in the February 2013 issue of the American Journal of Transplantation.
Over the study period, there was an increase in the percentage of donors over 40 years old, obese donors, and donors with glucose intolerance. These results demonstrate important trends in acceptance of older and more obese donors. To learn more about this study, please click here.
|
Under the ESRD Quality Measures Development and Maintenance contract, Arbor Research will convene four technical expert panels in Baltimore on April 16-17, 2013. The panels will consider evidence and propose recommendations for measures to assess the quality of care in the areas of mineral bone disorder, pediatric peritoneal dialysis adequacy, dialysis adequacy, and preventive care.
In May 2012, clinical technical expert panels convened and proposed recommendations related to anemia management and hospitalization. A report of these proceedings is available on www.DialysisReports.org (please click here to go directly to the report).
Following the 2012 panels, Arbor Research and the University of Michigan Kidney and Epidemiology Cost Center developed candidate measures that took into account Centers for Medicare & Medicaid Services (CMS) guidance, and additional input from the technical expert panels. These candidate measures will be available for public comment on the CMS website in mid-March 2013.
|
DOPPS Practice Monitor 
On January 15, 2013, the Dialysis Outcomes and Practice Patterns Study (DOPPS) hosted a Web conference to discuss the latest data available via the DOPPS Practice Monitor (DPM). A recording of this event is available on the DPM website.
Since its launch in November 2010, the DPM has provided objective surveillance of clinical trends as dialysis facilities adjust to federally mandated changes in reimbursement for dialysis care. To learn more about the DOPPS Practice Monitor, please click here.
|
Project News in Brief
The DOPPS will attend these upcoming scientific meetings:
- 44th National Symposium of the American Nephrology Nurses' Association (ANNA) on April 23rd in Las Vegas.
- Annual Dialysis Conference (ADC) on March 10, 2013 in Seattle.
For more information about the DOPPS, please visit www.DOPPS.org.
The PDOPPS (Peritoneal Dialysis Outcomes and Practice Patterns Study) has announced that the study will be initiated in the United Kingdom, Canada, Japan, and the United States later this year. For more about PDOPPS, please click here.
The new EPOCH-RRT (Empowering Patients on Choices for Renal Replacement Therapy) project hosted its first investigator meeting on February 4, 2013. This project is funded by a contract from the Patient-Centered Outcomes Research Institute (PCORI) to study the selection of dialysis modality for kidney failure. For more information about this project, please click here.
The first quarterly preview period for the CMS Dialysis Facility Compare measures was February 1-15. During this time, dialysis facilities previewed their measures via a secure portal of the www.DialysisReports.org website. These measures will be publicly available on the Medicare.gov Dialysis Facility Compare in April. Click here to view our complete portfolio of projects.
|
Demographic, metabolic, and blood pressure characteristics of living kidney donors spanning five decades. Taler SJ, et al; Am J Transplant.
The DOPPS Practice Monitor for US Dialysis Care: Trends Through December 2011. Fuller DS, et al; Am J Kidney Dis. Reduced survival and quality of life following return to dialysis after transplant failure: the Dialysis Outcomes and Practice Patterns Study. Perl J, et al; Nephrol Dial Transplant. Public Policy Series: Dialysis Outcomes and Practice Patterns Study (DOPPS): Its strengths, limitations, and role in informing practices and policies. Robinson BM, et al; Clin J Am Soc Nephrol. Hemoglobin A1c levels and mortality in the diabetic hemodialysis population: Findings from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Ramirez SPB, et al; Diabetes Care. Longer dialysis session length is associated with better intermediate outcomes and survival among patients on in-center three times per week hemodialysis: Results from the DOPPS. Tentori F, et al; Nephrol Dial Transplant. Blood pressure levels and mortality risk among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Robinson BM, et al; Kidney Int. Dialysis dose scaled to body surface area and size-adjusted, sex-specific patient mortality. Ramirez SPB, et al; Clin J Am Soc Nephrol. Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: Results of the A2ALL cohort. Kulik LM, et al; Am J Transplant. Click here to search all Arbor Research publications. |
|
|
|
|
